Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HDIOK
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
EGFR-ADC-08 (DAR4)
|
|||||
| Synonyms |
EGFR ADC 08 (DAR4)
Click to Show/Hide
|
|||||
| Organization |
Suzhou Medilink Therapeutics Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Esophageal cancer [ICD11:2B70]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.3
|
|||||
| Structure |
|
|||||
| Antibody Name |
Cetuximab
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
EGFR-ADC-08(DAR4) linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.